• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Jordan S. Orange, Elham M. Hossny, +13 authors Charlotte Cunningham-Rundles
  • Medicine
  • The Journal of allergy and clinical immunology
  • 2006 (First Publication: 1 April 2006)
  • Human immunoglobulin prepared for intravenous administration (IGIV) has a number of important uses in the treatment of disease. Some of these are in diseases for which acceptable treatmentContinue Reading
  • Jordan S. Orange, Mark Ballow, +16 authors Rohit Katial
  • Medicine
  • The Journal of allergy and clinical immunology
  • 2012 (First Publication: 1 September 2012)
  • A major diagnostic intervention in the consideration of many patients suspected to have primary immunodeficiency diseases (PIDDs) is the application and interpretation of vaccination. Specifically,Continue Reading
  • Mark Ballow
  • Medicine
  • The Journal of allergy and clinical immunology
  • 2002 (First Publication: 1 April 2002)
  • As a group, antibody deficiencies represent the most common types of primary immune deficiencies in human subjects. Often symptoms do not appear until the latter part of the first year of life, asContinue Reading
  • Joel M. Bernstein, Mark Ballow, Patrick M. Schlievert, Gary Rich, Cheryl L. Allen, Diane Dryja
  • Medicine
  • American journal of rhinology
  • 2003 (First Publication: 1 November 2003)
  • Background The pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis is still an enigma; however, the molecular biology of this disease is beginning to become unraveled and theContinue Reading
  • Mark Ballow
  • Medicine
  • The Journal of allergy and clinical immunology
  • 2011 (First Publication: 1 February 2011)
  • Intravenous immune globulin (IVIG) is an important treatment modality in patients with humoral or B-cell immune deficiency as replacement therapy. Soon after its introduction in the early 1980s forContinue Reading